Julie Ann Dopheide, PharmD

TitleProfessor of Clinical Pharmacy
InstitutionUniversity of Southern California
DepartmentClinical Pharmacy and Pharmaceutical Econ. and Policy
AddressPSC 602
Health Sciences Campus
Los Angeles CA 90089-9121
Phone+1 323 442 1454
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Research Interest
    Dr. Dopheide's work focuses on clinical research involving inpatients with psychiatric illness and expanding roles for psychiatric pharmacists in primary care settings. She has investigated the tolerability of Depakote loading in patients with bipolar disorder and has examined the use of psychotropic medications in hospitalized persons with eating disorders. Dr. Dopheide has collaborated with her PGY-2 psychiatric pharmacy residents to demonstrate the value of integrating psychiatric pharmacists into the medical home to provide comprehensive medication management for patients with both psychiatric and medical conditions.

    Dr. Dopheide has published over 40 articles in peer-reviewed journals, textbooks and educational publications, on topics including ADHD, depression, sleep, insomnia and drug-induced psychiatric disorders.

    Dr. Dopheide is a Professor of Clinical Pharmacy, Psychiatry and the Behavioral Sciences at the University of Southern California School of Pharmacy, and Keck School of Medicine. She is actively involved in teaching pharmacy students, medical students and psychiatry and pharmacy residents through didactic and clinical teaching.

    Dr. Dopheide’s clinical practice is divided between adults, adolescents and children with psychiatric illness. She serves on Los Angeles County’s department of mental health pediatric psychotropic guideline development committee. As part of a multidisciplinary treatment team, Dr. Dopheide makes recommendations to optimize treatment for psychiatric illnesses including schizophrenia, mood disorders, anxiety, attention-deficit hyperactivity disorder, chronic insomnia and substance abuse.

    Dr. Dopheide is the immediate past president of the College of Psychiatric and Neurologic Pharmacists (CPNP). She is also actively involved with the American Society of Health System Pharmacist’s (ASHP), the American Pharmacists Association, and the National Alliance of the Mentally (NAMI). She is the PGY2 psychiatric pharmacy residency program director and supervises the resident in providing medication therapy management for outpatients in the Center for Community Health safety net clinic located in downtown Los Angeles.

    Dr. Dopheide obtained her PharmD from the University of Nebraska College of Pharmacy in Omaha and went on to complete a residency in Psychiatric Pharmacy Practice at the University of Southern California Medical Center. She has over 40 publications on topics in psychopharmacology and clinical pharmacy. A Nebraska native, she now considers Southern California her home and enjoys rooting for both the Cornhuskers and the Trojans during football season.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Cho VM, Dopheide JA. Pharmacy resident teaching in psychiatry and neurology for pharmacy programs in the United States. Ment Health Clin. 2018 Jul; 8(4):163-168. PMID: 30155390.
      View in: PubMed
    2. Dopheide JA, Bostwick JR, Goldstone LW, Thomas K, Nemire R, Gable KN, Cates M, Caballero J, Smith T, Bainbridge J. Curriculum in Psychiatry and Neurology for Pharmacy Programs. Am J Pharm Educ. 2017 Sep; 81(7):5925. PMID: 29109559.
      View in: PubMed
    3. Gomez S, Dopheide J. Antipsychotic Selection for Acute Agitation and Time to Repeat Use in a Psychiatric Emergency Department. J Psychiatr Pract. 2016 Nov; 22(6):450-458. PMID: 27824777.
      View in: PubMed
    4. Stutzman D, Dopheide J. Acetylcysteine for treatment of autism spectrum disorder symptoms. Am J Health Syst Pharm. 2015 Nov 15; 72(22):1956-9. PMID: 26541950.
      View in: PubMed
    5. Williams AM, Dopheide JA. Nonpsychiatric medication interventions initiated by a postgraduate year 2 psychiatric pharmacy resident in a patient-centered medical home. Prim Care Companion CNS Disord. 2014; 16(6). PMID: 25834765; PMCID: PMC4374824.
    6. Nazarian PK, Dopheide JA. Psychiatric pharmacist management of depression in patients with diabetes. Prim Care Companion CNS Disord. 2013; 15(5). PMID: 24511443; PMCID: PMC3907323.
    7. Dopheide JA. Vilazodone's comparative merits yet to be demonstrated. Am J Health Syst Pharm. 2012 Sep 15; 69(18):1549. PMID: 22935936.
      View in: PubMed
    8. Wang I, Dopheide JA, Gregerson P. Role of a psychiatric pharmacist in a Los Angeles "Skid-Row" safety-net clinic. J Urban Health. 2011 Aug; 88(4):718-23. PMID: 21512832; PMCID: PMC3157501.
    9. Chung B, Dopheide JA, Gregerson P. Psychiatric pharmacist and primary care collaboration at a skid-row safety-net clinic. J Natl Med Assoc. 2011 Jul; 103(7):567-74. PMID: 21999031.
      View in: PubMed
    10. Dopheide JA. Iloperidone: Does it have a meaningful place in therapy? Am J Health Syst Pharm. 2011 Feb 15; 68(4):297. PMID: 21289322.
      View in: PubMed
    11. Dopheide JA, Pliszka SR. Attention-deficit-hyperactivity disorder: an update. Pharmacotherapy. 2009 Jun; 29(6):656-79. PMID: 19476419.
      View in: PubMed
    12. Dopheide JA. The role of pharmacotherapy and managed care pharmacy interventions in the treatment of ADHD. Am J Manag Care. 2009 May; 15(5 Suppl):S141-50. PMID: 19601689.
      View in: PubMed
    13. Dopheide JA. Paliperidone: An improvement over risperidone? Am J Health Syst Pharm. 2008 Mar 01; 65(5):401. PMID: 18281730.
      View in: PubMed
    14. Knox ED, Dopheide JA, Wincor MZ, Han PK. Depression screening in a university campus pharmacy: a pilot project. J Am Pharm Assoc (2003). 2006 Jul-Aug; 46(4):502-6. PMID: 16913394.
      View in: PubMed
    15. Dopheide JA. Recognizing and treating depression in children and adolescents. Am J Health Syst Pharm. 2006 Feb 01; 63(3):233-43. PMID: 16434782.
      View in: PubMed
    16. Gable KN, Dopheide JA. Psychotropic medication use at a private eating disorders treatment facility: A retrospective chart review and descriptive data analysis. Curr Ther Res Clin Exp. 2005 Nov; 66(6):572-88. PMID: 24764595; PMCID: PMC3997119.
    17. Dopheide JA. ASHP therapeutic position statement on the appropriate use of medications in the treatment of attention-deficit/hyperactivity disorder in pediatric patients. Am J Health Syst Pharm. 2005 Jul 15; 62(14):1502-9. PMID: 15998933.
      View in: PubMed
    18. Park SH, Gill MA, Dopheide JA. Visual compatibility of risperidone solution and lithium citrate syrup. Am J Health Syst Pharm. 2003 Mar 15; 60(6):612-3. PMID: 12659069.
      View in: PubMed
    19. Roe KK, Dopheide JA, Wincor MZ. Developing a partnership with NAMI and psychiatric pharmacists. Schizophr Bull. 2002; 28(3):525-9. PMID: 12645683.
      View in: PubMed
    Julie's Networks
    Derived automatically from this person's publications.
    People in Profiles who have published with this person.
    Related Authors
    People who share related concepts with this person.